Management Sciences for Health

This month in our 𝙂𝙡𝙤𝙗𝙖𝙡 𝙃𝙚𝙖𝙡𝙩𝙝 𝙄𝙢𝙥𝙖𝙘𝙩 newsletter, we look back on several transformative projects and look forward to new opportunities to apply, expand, and share our expertise. Whether exploring innovative #TB interventions, training #healthworkers in #climateresilience, or using the latest technology to map mosquito-borne diseases, our team remains dedicated to advancing knowledge in service to 𝗼𝘂𝗿 𝗰𝗼𝗿𝗲 𝗺𝗶𝘀𝘀𝗶𝗼𝗻: 𝘁𝗼 𝘀𝗮𝘃𝗲 𝗹𝗶𝘃𝗲𝘀, 𝗶𝗺𝗽𝗿𝗼𝘃𝗲 𝗵𝗲𝗮𝗹𝘁𝗵 𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀, 𝗮𝗻𝗱 𝗿𝗲𝗮𝗹𝗶𝘇𝗲 𝗮 𝘄𝗼𝗿𝗹𝗱 𝘄𝗵𝗲𝗿𝗲 𝗲𝘃𝗲𝗿𝘆𝗼𝗻𝗲 𝗵𝗮𝘀 𝘁𝗵𝗲 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆 𝗳𝗼𝗿 𝗮 𝗵𝗲𝗮𝗹𝘁𝗵𝘆 𝗹𝗶𝗳𝗲.  As always, we are eager to hear #yourfeedback in the comments section—and be sure to #subscribe to stay up to date with our latest #webinars, #jobopportunities, and more! #HealthForAll #GlobalHealthImpact

New Study Looks at Improving Survival Predictions for Breast Cancer Treatment in Indonesia A new publication by Management Sciences for Health experts and colleagues from #Indonesia digs into an important aspect of health technology assessment to make better decisions about breast cancer treatment. It's a little complex, so let's break it down. First, what is Health Technology Assessment (#HTA)? HTA is a process used to evaluate the benefits, risks, and costs of new health treatments or technologies, like medicines, medical devices, or procedures. It helps decision makers, like governments or health organizations, determine whether a treatment is worth offering to patients, based on its effectiveness, safety, and value for money. Essentially, it’s a way to make sure that health care resources are used in the best possible way to improve people's health. When we talk about resource allocation, prioritization, and evidence-based decision making, HTA is a tool to help us do that well. At Management Sciences for Health, we're lucky to have some of the top talent in the industry—including internationally recognized HTA pros like Rabia Sucu and Chris Suharlim—and many years of experience establishing HTA systems in different countries. One of the challenges with HTA is that it needs reliable and pertinent data inputs. Some of those data aren't always available in the contexts where we work. (Another reason why MSH focuses on helping countries build strong data systems). In the absence of those country-specific data points, HTA pros turn to statistical modelling. But are those models always right? Imagine you're using HTA to figure out the best breast cancer treatment options for Indonesia but you don't have enough data from Indonesia. You may turn to a breast cancer data set from, say, the United States. In such an example, your modelling will be quite interesting considering the differences between the United States and Indonesia. If available, you'd probably want to use a data set from a country more similar to Indonesia. Which brings us to the importance of our publication. In the words of one of the authors, Dr. Chris Suharlim, "This is a particularly meaningful milestone. The paper embodies a true south-to-south collaboration by adapting the Philippines’ breast cancer model and calibrating it with Indonesian cancer registry data. It’s the first time HTA modeling in Indonesia has integrated local real-world evidence in this way—demonstrating a pragmatic path for using available local data in LMICs, despite ongoing data infrastructure challenges." https://lnkd.in/dfsyW-J4 Ministry of Health of the Republic of Indonesia Center for Health Policy and Management, FK-KMK, Universitas Gadjah Mada Hector E. Castro J. Anika Ruisch Justice Nonvignon Anupama S. #HeathTechnologyAssessment #DataForDecisionMaking #HealthTech #CostEffectiveness #BreastCancerTreatment #RealWorldEvidence #HealthPolicy #DataDrivenDecisions

Everyone has a role to play in fighting #superbugs! And that's what we're doing in #Nigeria. One aspect of the multipronged approach required to combat what's known as antimicrobial resistance (AMR) includes raising awareness among the general public and equipping everyone with knowledge and tools to do their part. And who is better positioned to do that than the media outlets and community based organizations people trust? That is why together with the Fleming Initiative and the Federal Ministry of Health and Social Welfare Nigeria we are holding workshops to empower community-based organizations and journalists to advocate for responsible antibiotic use and share information about the importance of good hygiene practices, the cornerstone of preventing infections. Organizations like Girl Child Freedom At The Grassroot are integrating AMR awareness into their initiatives, emphasizing the critical connection between sanitation and proper antibiotic use. Through strategies such as local radio programs, social media campaigns, and outreach, these groups aim to build a well-informed public. The workshops also gave journalists the tools to accurately report on AMR, fostering stronger accountability and healthier practices. This collaboration marks a vital step in safeguarding public health, reinforcing the need for informed, collective action. What other initiatives do you think we should consider? Leave us a comment. We're eager for your thoughts! #PublicHealth #FlemingFund #CommunityAdvocacy #Nigeria #AntibioticResistance #HealthEducation #SustainableChange #OneHealth Babatunde Akinola Dozie Ezechukwu Mott MacDonald Internews Bhekisisa Centre for Health Journalism Health Policy Watch https://lnkd.in/dSWKEpbJ

📢 "Advancing Health Equity: Universal Access to Health Products" Join us for a side event at the 58th session of the Commission on Population and Development (CPD58) to discuss advancing access to safe, effective health products for all. This event aims to catalyze actions to ensure all people, regardless of location or income, have access to the health products necessary for achieving good health at all stages of life. 📅 April 10, 2025 🕒 13:15-14:30 (EST)  🏢 United Nations, New York #HealthEquity #HealthForAll #GlobalHealth #SDG3 #CPD58 #Accesstomeds #PSS Francis Aboagye-Nyame US Pharmacopeia World Health Organization PATH https://lnkd.in/dUV7vWDa

Today is #WorldTBDay and we're dedicating our newsletter to the work our staff and partners do every day to fight the world's top infectious disease killer. Enjoy and share our latest research, tools, and stories. We'd love to hear your thoughts! #WorldTBDay2025

📣 WEBINAR TOMORROW 📣 Join our colleague Saba Waseem as she moderates this discussion with a dynamic group of experts convened by the TBPPM Learning Network to examine ways to make #tuberculosis care more accessible and affordable. With examples from #India, #Indonesia and #SouthAfrica Register! https://lnkd.in/d5aQ8Ugn #TB #YesWeCanEndTB #WorldTBDay #EndTB #LungHealth #MdrTB #PublicHealth #GlobalHealth #HealthFinancing #InfectiousDisease #HealthFinancing #DRM #PrimaryHealthCare #PHC #OOPC #Webinar

We'd be remiss if we didn't share highlights of our closing session at #AfHEA2025 last week in Kigali, where experts gathered to discuss critical issues shaping a resilient African health system through the lens of health economics and policy. We are proud to have contributed to a series of discussions over the five-day conference, including Friday's session on Equity, Social Determinants, and Health Inequalities in Africa. MSH’s Lelisa Fekadu Assebe presented insights from "Incorporating Equity and Financial Protection Criteria into Essential Benefits Package Design: A Case Study of Infectious Disease Interventions in Ethiopia." The analysis revealed significant disparities in health outcomes and financial protection, showing that lower-income groups benefited more from financial risk protection, while health gains were more evenly distributed across income levels. This highlights the need to prioritize interventions that maximize both health impact and financial protection. Key recommendations: ▶️ Strengthen policies that integrate equity and financial protection into Essential Benefits Package design. ▶️ Prioritize interventions that offer both high health benefits and financial risk reduction. ▶️ Improve transparency in resource allocation using standardized ranking and aggregation methods. ▶️ Enhance data collection and analysis to better address health inequalities. ▶️ Foster ongoing discussions on refining methodologies for equitable healthcare decision-making. The session emphasized the importance of explicit priority-setting in health care planning to reduce inequalities. By adopting standardized equity measures and financial protection criteria, health systems can improve access to essential services and move closer to Universal Health Coverage. It is crucial that healthcare decisions are data-driven, transparent, and inclusive, particularly for the most vulnerable, ensuring that access to health services is a right for all. #Healthfinancing #PrimaryHealthCare #PHC #UniversalHealthCoverage #UHC #HealthEquity #EBP #DataforDecisionMaking #SDGs

Friends of MSH at #AfHEA2025: Don't miss tomorrow's session with our colleague Lelisa Assebe 👇 "Equity and social determinants, and health inequalities in Africa: Incorporating equity and financial protection criteria into essential benefits package design; a case study of infectious disease interventions in Ethiopia" 📅 Date: March 14, 2025 ⏰ Time: 10:00 – 11:30 CAT 🌍 Location: AD11, Kigali Convention Centre #HealthFinancing #HealthEconomics #HealthForAll #PrimaryHealthCare #SDGs #UHC #HSS #HealthEquity #Ethiopia #FinancialProtection #InfectiousDiseases

📣Pharmaceutical & supply chain professionals: Tune in on March 18 at 9:00 AM eastern time to hear from MSH’s Dr Andrew Brown on the post-USAID environment. He joins Greg Schlegel CPIM, CSP, Jonah, Ahmad Habash, Craig Usswald to discuss: 🟨 How in-country supply chain teams have been affected 🟨 Immediate and long-term response plans 🟨 Ideas for supply chain risk mitigation activities Register here: https://lnkd.in/dWbiVqdb #pharmaceuticalmanagement #PSS #supplychain #SAPICS #supplychainmanagement #Supplychainrisk #SCRMC The Supply Chain Risk Management Consortium SAPICS

Déclaration de MSH sur la décision du juge relative à l’action en justice La décision rendue cette semaine par la cour de district sur l'aide étrangère a été une victoire importante. C'est une victoire pour les contribuables américains, la sécurité nationale américaine, la démocratie américaine et, surtout, pour la générosité américaine, qui a amélioré la vie de millions de personnes dans le monde tout en soutenant des alliés stables et en développant des marchés solides pour les entreprises américaines. Les ordres d'arrêter le travail émis en janvier et le chaos qui s'en est suivi ont retardé et refusé l'accès à des soins et des médicaments vitaux à d'innombrables personnes et ont menacé la sécurité sanitaire mondiale. À MSH, nous travaillons main dans la main avec les communautés pour sauver des vies et améliorer la santé des personnes les plus vulnérables dans le monde. Nous connaissons l'impact douloureux de ces arrêts de travail : les médicaments ne sont pas livrés, les maladies mortelles et résistantes aux médicaments ne sont pas suivies et les patients sont refoulés des cliniques fermées. Nous attendons avec impatience la mise en œuvre rapide par le gouvernement de l'ordonnance du juge Ali et espérons que le pouvoir exécutif s'acquittera de son obligation constitutionnelle d'utiliser les fonds alloués par le Congrès de manière transparente et en toute bonne foi. Nous continuerons à plaider notre cause devant les tribunaux pour que le gouvernement respecte ses obligations contractuelles et constitutionnelles.